Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matteo, di Minno"'
Autor:
Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss 2 (2024)
Despite major advances in prophylaxis, no repeated dosing regimen with currently employed extended-half-life or non-factor products replaces the advantages of a long-term cure in persons with severe congenital hemophilia A and B (HA, HB). They indeed
Externí odkaz:
https://doaj.org/article/2caedf3070ec4fd3a6ae3d0ea3de9d4c
Autor:
Roberta Lupoli, Ilenia Calcaterra, Pasquale Ambrosino, Rosalba Giacco, Marilena Vitale, Giuseppe Della Pepa, Angela Albarosa Rivellese, Gabriella Iannuzzo, Lutgarda Bozzetto, Matteo Di Minno
Publikováno v:
Biomedicines, Vol 12, Iss 11, p 2595 (2024)
Background: Endothelial dysfunction is recognized as an early modification involved in the pathogenesis of vascular diseases. Evidence suggests that the Mediterranean Diet (MD) is associated with endothelial function improvement and, in turn, plays a
Externí odkaz:
https://doaj.org/article/3c2f3d9522464e4a88763b3196d46e93
Autor:
Karin, Berger, Angelika, Batorova, Rhonda, Bohn, Matteo, di Minno, Pier Mannuccio, Mannucci, Kaan, Kavakli, Wolfgang, Schramm, Louis, Aledort
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 28(6)
Autor:
Roseline D'Oiron, Giovanni Di Minno, Paola Giordano, Munira Borhany, John Grainger, Matteo Di Minno, Karina Meijer
Publikováno v:
Haematologica.
Standard treatment for Glanzmann thrombasthenia is platelet transfusion. Recombinant activated factor VII has been shown to be successful in patients with Glanzmann thrombasthenia with platelet antibodies or who are refractory to platelet transfusion
Autor:
Roseline D'Oiron, Giovanni Di Minno, Paola Giordano, Munira Borhany, John Grainger, Matteo Di Minno, Karina Meijer
Standard treatment for Glanzmann thrombasthenia, a severe inherited bleeding disorder, is platelet transfusion. Recombinant factor VIIa is reported to be effective in Glanzmann thrombasthenia with platelet antibodies and/or refractoriness to platelet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b51def189e316636505ebddb0b0761
http://hdl.handle.net/11588/620528
http://hdl.handle.net/11588/620528
Autor:
Scarpa, R., Soscia, E., Peluso, R., Atteno, M., Manguso, F., Del Puente, A., Spanò, A., Sirignano, C., Oriente, A., Matteo Di Minno, Iervolino, S., Salvatore, M.
Publikováno v:
Journal of rheumatology 33 (2006): 1315–1319.
info:cnr-pdr/source/autori:Scarpa R, Socia E, Peluso R, Atteno M, Manguso F, Del Puente A, Spano A, Sirignano C, Oriente A, Di Minno MN, Iervolino S, Salvatore M./titolo:Nail and distal interphalangeal joint in psoriatic arthritis/doi:/rivista:Journal of rheumatology/anno:2006/pagina_da:1315/pagina_a:1319/intervallo_pagine:1315–1319/volume:33
Scopus-Elsevier
Europe PubMed Central
info:cnr-pdr/source/autori:Scarpa R, Socia E, Peluso R, Atteno M, Manguso F, Del Puente A, Spano A, Sirignano C, Oriente A, Di Minno MN, Iervolino S, Salvatore M./titolo:Nail and distal interphalangeal joint in psoriatic arthritis/doi:/rivista:Journal of rheumatology/anno:2006/pagina_da:1315/pagina_a:1319/intervallo_pagine:1315–1319/volume:33
Scopus-Elsevier
Europe PubMed Central
OBJECTIVE: To study distal interphalangeal (DIP) joints in patients with psoriatic arthritis (PsA) with or without onychopathy, using magnetic resonance imaging (MRI). METHODS: Twenty-three patients with PsA (9/14 F/M, median age 47 yrs), 12 with ony
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5b91fe3759fcedf337360d7a45b4f359
http://www.cnr.it/prodotto/i/13686
http://www.cnr.it/prodotto/i/13686